According to the 2025 programme strategy of the National Research, Development and Innovation Fund (NRDI Fund), this year HUF 40 billion is available in the National Research Excellence Programme (NKKP) to support leading researchers and research projects. This is more than double the amount allocated a year earlier. In the first and second decision rounds of the NKKP Excellence sub-programme, an excellence-based research funding scheme, the Research Council of Hungary (KKT) awarded HUF 700 million to five outstanding researchers.

The groundbreaking research result of Pharmacoidea Kft., based in Szeged – a new diagnostic procedure for the early detection of Alzheimer’s disease from blood – has been shortlisted at the Reuters Events Pharma Awards in the category “Most Valuable Scientific Breakthrough/Discovery”. Pharmacoidea’s outstanding research has been supported in several projects by the National Research, Development and Innovation Fund and continues to receive support.

Research into modern, effective medicines for psychiatric and gynaecological diseases, advancing renewable fuel production, and developing an AI-based system that enhances national security by predicting geopolitical crises – these and similar products and services, significantly improving people’s wellbeing and sense of security, will be created from the nearly HUF 15 billion funding framework announced at the end of last year by the National Research, Development and Innovation Office (NRDI Office) for the large enterprise sector.

The XPAND Program, initiated by the National Innovation Agency (NIÜ), is designed to help Hungarian startups and SMEs enter international markets, connect with global investors, and expand their business networks.